Sessa Roberto, Hata Akiko
Cardiovascular research institute, University of California San Francisco, CA 94158, USA.
Pulm Circ. 2013 Apr;3(2):315-28. doi: 10.4103/2045-8932.114758.
MicroRNAs (miRNAs) are a class of small noncoding RNA which exert post-transcriptional gene regulation activity by targeting messenger RNAs. miRNAs have been found to be involved in various fundamental biological processes and deregulation of miRNAs is known to result in pathological conditions. In this review, we provide an overview of recent discoveries on the role played by this class of molecules in lung development and in pulmonary diseases, such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and pulmonary artery hypertension. Considering the relevant role of these miRNAs under physiological and pathological conditions, they represent new clinical targets as well as diagnostic and prognostic tools. Therefore, this review pays special attention to recent advances and possible future directions for the use of miRNAs for clinical applications.
微小RNA(miRNA)是一类小的非编码RNA,其通过靶向信使RNA发挥转录后基因调控活性。已发现miRNA参与各种基本生物学过程,并且已知miRNA失调会导致病理状况。在本综述中,我们概述了这类分子在肺发育以及肺部疾病(如哮喘、囊性纤维化、慢性阻塞性肺疾病和肺动脉高压)中所起作用的最新发现。考虑到这些miRNA在生理和病理条件下的相关作用,它们代表了新的临床靶点以及诊断和预后工具。因此,本综述特别关注miRNA临床应用的最新进展和可能的未来方向。